版本:
中国

BRIEF-Tracon Pharmaceuticals announces $21 mln common stock purchase agreement with Aspire Capital Fund

March 14 Tracon Pharmaceuticals Inc

* Tracon Pharmaceuticals announces $21 million common stock purchase agreement with Aspire Capital Fund, LLC

* Tracon Pharmaceuticals Inc - aspire capital has made an initial purchase of $1.0 million of Tracon common stock at $4.50 per share

* Tracon Pharmaceuticals - aspire capital has committed to purchase up to $20.0 million of additional shares of company's common stock at Tracon's request

* Tracon Pharmaceuticals Inc - proceeds from agreement will be used to further advance company's drug development pipeline Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐